Artwork

Sisällön tarjoaa Oleksandr Yagensky. Oleksandr Yagensky tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Ep#018: Bringing Proteomics One Step Closer to Clinics with Dr. Oliver Rinner

43:27
 
Jaa
 

Manage episode 275595016 series 2800366
Sisällön tarjoaa Oleksandr Yagensky. Oleksandr Yagensky tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
We are back! The first episode of Season 2 of the Personalized Medicine Podcast is out! In this episode, our host Oleksandr Yagensky sat down with Dr. Oliver Rinner, co-founder, and CEO of Biognosys, a proteomics technology company. We discussed the growing role of proteomics in healthcare, its impact on biomarker discovery, and the development of new therapeutics.
Together with Oliver, we talk about:
◦ Startup story of Biognosys
◦ Transitioning from academia to entrepreneurship
◦ Impact of proteomics on pharma industry
◦ Role of proteomics in biomarker discovery
◦ Differences between targeted and discovery mass spectrometry
◦ Role of AI and ML in the analysis of OMICs data
◦ How can proteomics take up a mainstream role in clinical diagnostics?
◦ The outlook on the personalized medicine of the future
Get in touch with Oliver:
◦ Twitter: @oliverrinner, @biognosys
◦ Linkedin: https://www.linkedin.com/in/orinner/
◦ Web: https://biognosys.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
  continue reading

48 jaksoa

Artwork
iconJaa
 
Manage episode 275595016 series 2800366
Sisällön tarjoaa Oleksandr Yagensky. Oleksandr Yagensky tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
We are back! The first episode of Season 2 of the Personalized Medicine Podcast is out! In this episode, our host Oleksandr Yagensky sat down with Dr. Oliver Rinner, co-founder, and CEO of Biognosys, a proteomics technology company. We discussed the growing role of proteomics in healthcare, its impact on biomarker discovery, and the development of new therapeutics.
Together with Oliver, we talk about:
◦ Startup story of Biognosys
◦ Transitioning from academia to entrepreneurship
◦ Impact of proteomics on pharma industry
◦ Role of proteomics in biomarker discovery
◦ Differences between targeted and discovery mass spectrometry
◦ Role of AI and ML in the analysis of OMICs data
◦ How can proteomics take up a mainstream role in clinical diagnostics?
◦ The outlook on the personalized medicine of the future
Get in touch with Oliver:
◦ Twitter: @oliverrinner, @biognosys
◦ Linkedin: https://www.linkedin.com/in/orinner/
◦ Web: https://biognosys.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
  continue reading

48 jaksoa

Toate episoadele

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas